Despite the previously recognized impact of IGF2BP3 on cell proliferation and apoptosis in cancer cells (Huang et al, 2020), we did not observe significant effects on these processes upon modulating IGF2BP3 expression in MCC cells. This evidence concerns the gene IGF2BP3 and Merkel cell skin cancer.